Big Board

Content Ideas
Result Content Idea Research
Result Content Idea Research
1 Better Coronavirus Stock: BioNTech or Vir Biotechnology?
2 BioNTech to Acquire GMP Manufacturing Site to Expand COVID-19 Vaccine Production Capacity in First Half 2021
3 Pfizer urged to hold off on coronavirus vaccine until late November: report
4 Pfizer, BioNTech 'quietly' usher a 5th COVID-19 jab into the clinic: analyst
5 Pfizer and BioNTech Propose Expansion of Pivotal COVID-19 Vaccine Trial
6 Pfizer and BioNTech To Supply Qatar With Their bnt162 Mrna-Based Vaccine Candidate Against Sars-Cov-2
7 BioNTech to Receive up to €375M in Funding from German Federal Ministry of Education and Research to Support COVID-19 Vaccine Program BNT162
8 Pfizer, BioNTech report 'strong' immune response in animals to COVID-19 mRNA vaccine candidate
9 Pfizer partner BioNTech sees no role for its vaccine in UK challenge trial
10 Pfizer, BioNTech Inch Closer to COVID-19 Vax Deal with EU
11 Pfizer and BioNTech Announce Data from Preclinical Studies of mRNA-based Vaccine Candidate Against COVID-19
12 Moderna, BioNTech, Pfizer stocks rally after AstraZeneca COVID-19 vaccine trial is reportedly halted
13 Why BioNTech Stock Is Falling Today
14 Is BioNTech's Coronavirus Vaccine Candidate a Game-Changer for Investors?
15 Pfizer/BioNTech COVID-19 vaccine candidate shows encouraging action in preclinical studies
16 BioNTech Stock Boosted by COVID-19 Vaccine Pact
17 Where the 4 major coronavirus vaccine candidates currently stand
18 4 Coronavirus Vaccine Stocks the Bill & Melinda Gates Foundation Is Betting On
19 Covid-19 Vaccine Update: Inovio Stock Tumbles After Trial Is Halted
20 Covid-19 roundup: Fauci reiterates October vaccine OK 'unlikely'; Pfizer and BioNTech reserve 200M doses for EU
21 Vaccine could be ready for approval by October, CEO says
22 Navajo Nation to participate in Pfizer-BioNTech COVID-19 vaccine trial
23 Pfizer and BioNTech may know before rivals about Covid vaccine shot
24 BioNTech Investor Fortunes Rise and Fall on Headlines, Pacts and Funding
25 Moderna or BioNTech: J.P. Morgan Lays Odds On the Race to a COVID-19 Vaccine
26 BioNTech, Bayer, Valeo Pharma: Share price jump ahead of quarterly results
27 Shanghai Fosun Pharma, Sinopharm Group sign deal to supply BioNTech coronavirus vaccine candidate
28 The Daily Biotech Pulse: Moderna Inks 2 R&D Deals, BioNTech To Buy Manufacturing Facility, Dyne Therapeutics IPO
29 Reality Check For COVID Vaccines: Caution Moderna, BioNTech, Novavax
30 BRIEF-Pfizer And Biontech Propose Expansion Of Pivotal Covid-19 Vaccine Trial
31 J.P. Morgan Stick to Their Hold Rating for BioNTech SE
32 Are Investors Keen On Selling Holdings In BioNTech SE (NASDAQ:BNTX)?
33 Pfizer, BioNTech Seek to Expand Enrollment of Vaccine Trial
34 BioNTech Buys German Factory to Boost Covid Vaccine Capacity
35 Under pressure, Pfizer, Moderna (and soon AstraZeneca) publish COVID-19 vaccine protocols
36 BNTX Stock, NVAX Stock Up As Covid-19 Vaccine Efforts Advance
37 There are four coronavirus vaccines in late-stage studies — here’s how they differ
38 BioNTech shares are trading higher, not currently seeing company-specific news from the session. Strength potentially related to continued vaccine interest as coronavirus concerns grow going into the fall.
39 Here is a bargain stock you should look at : BioNTech SE (BNTX)
40 Fosun/BioNTech could supply Macau and HK with 10 mln Covid-19 vaccine doses
41 BioNTech makes a deal with Novartis
42 mRNA Therapy Market Size is Thriving Worldwide with Topmost Companies Like:Moderna, BioNTech, Pfizer, Arcturus Therapeutics Holdings Inc., Astrazeneca, CureVac
43 3 Top Biotech Stocks to Buy Right Now
44 COVID-19 Clinical Trials Market will touch a new level in upcoming year with Top Key Players like INOVIO Pharmaceuticals, AbbVie Inc., BioNTech SE, Novavax, Takeda
45 If You Invested $1,000 in Inovio Pharmaceuticals in January, This Is How Much You'd Have Now
46 Adding $500 to These 3 Top Stocks Would Be a Brilliant Move
47 Global mRNA Cancer Vaccines and Therapeutics Market Outlook 2020-2026 : Moderna Therapeutics, CureVac, Translate Bio, BioNTech, Sangamo Therapeutics
48 Sell Moderna Stock, Analyst Says, Because Covid Vaccine Competition Is Fierce
49 Many Iowans plan to wait on taking coronavirus vaccine: poll
50 Pfizer and BioNTech Announce an Agreement with U. S. Government for up to 600 Million Doses of mRNA-based Vaccine Candidate Against SARS-CoV-2
51 Here's My Top Coronavirus Vaccine Stock to Buy
52 BioNTech Publishes Data from mRNA-based BNT111 FixVac Melanoma Trial in Nature
53 BioNTech to Hold Webcast to Present Early Positive Data from Ongoing Phase 1/2 Study of mRNA-based Vaccine Candidate Against SARS-CoV-2
54 3 Ways to Cash In on Low Taxes While They Last
55 BioNTech Announces Proposed Public Offerings Nasdaq:BNTX
56 Pfizer and BioNTech Announce Early Positive Update from German Phase 1/2 COVID-19 Vaccine Study, Including First T Cell Response Data
57 BioNTech and Pfizer announce completion of dosing for first cohort of Phase 1/2 trial of COVID-19 vaccine candidates in Germany
58 Pfizer and BioNTech began late-stage human trial for coronavirus vaccine Monday
59 Unprecedented Global Turmoil Underlines Need for Effective Diagnostics
60 Pfizer and BioNTech to Supply Japan with 120 Million Doses of Their BNT162 mRNA-Based Vaccine Candidate
61 A Second Wave of Coronavirus Could Be Coming: 3 Stocks to Buy Before It Hits
62 Pfizer, BioNTech share clinical data linking favored COVID-19 vaccine to improved tolerability
63 BioNTech to Raise USD 250 Million in Private Placement
64 BioNTech Announces Closing of $512 Million Underwritten Offering of American Depositary Shares
65 BioNTech Announces First Quarter 2020 Financial Results and Corporate Progress
66 German Biotech Sees Its Coronavirus Vaccine Ready for Approval by December
67 BioNTech Announces Strategic Collaboration with Regeneron to Advance FixVac and Libtayo® (cemiplimab) Combination in Melanoma
68 BioNTech and Fosun Pharma Announce Start of Clinical Trial of mRNA-based COVID-19 Vaccine Candidate in China
69 Here's the Bigger Story About Moderna That You Might Be Missing
70 BioNTech Announces Second Quarter 2020 Financial Results and Corporate Progress
71 Pfizer, BioNTech get fast-track from FDA for Covid-19 vaccines
72 Pfizer and BioNTech to Supply Canada with their BNT162 mRNA- Based Vaccine Candidate
73 BioNTech and Pfizer announce regulatory approval from German authority Paul-Ehrlich-Institut to commence first clinical trial of COVID-19 vaccine candidates
74 Pfizer, BioNTech are set to begin US coronavirus vaccine trial
75 Thinking about trading options or stock in Nikola Corp, BioNTech, Johnson & Johnson, General Electric, or Tesla?
76 BioNTech Completes Acquisition of Neon Therapeutics Nasdaq:BNTX
77 Rna Vaccines Market Size, Regional Insights and Industry Dynamics By 2027 | By Top Leading Vendors – Curevac, Moderna Therapeutics, Translate Bio, Biontech, Sangamo Therapeutics, Argos Therapeutics, In-cell-art
78 Pfizer, BioNTech to ramp up COVID-19 vaccine tests, plot major trial boost in fall
79 Pfizer and BioNTech to Co-develop Potential COVID-19 Vaccine
80 Personalized Cancer Vaccines Market 2020-2026 is Flourishing Worldwide || Leading Players – F. Hoffmann-La Roche Ltd, CureVac AG, Celldex Therapeutics, BioNTech SE, Advaxis, Inc
81 Personalized Cancer Vaccines Market 2020-2026 In Depth Business Growth Analysis || Leading Players – F. Hoffmann-La Roche Ltd, CureVac AG, Celldex Therapeutics, BioNTech SE, Advaxis, Inc
82 mRNA Cancer Vaccines and Therapeutics Market Research & Clinical Advancements by 2028 | Moderna Therapeutics, eTheRNA, BioNTech
83 Covid vaccine: Russia may be the first to announce data from final trial
84 Moderna's Coronavirus Treatment Transforms Body Into Vaccine-Making Machine
85 Pfizer and BioNTech Announce Further Details on Collaboration to Accelerate Global COVID-19 Vaccine Development
86 Pfizer and BioNTech Announce Early Positive Data from an Ongoing Phase 1/2 study of mRNA-based Vaccine Candidate Against SARS-CoV-2
87 Is BioNTech Stock a Buy?
88 Why Is Everyone Talking About BioNTech Stock?
89 Pfizer, BioNTech score deal to supply 120M Covid-19 vaccine doses to Japan
90 No takeover approach, says COVID-19 vaccine developer BioNTech
91 BioNTech to Report Second Quarter 2020 Financial Results and Operational Update on August 11, 2020
92 Regeneron and BioNTech Partner on Immunotherapy Combo for Melanoma
93 Pfizer and BioNTech work on coronavirus vaccine
94 Better Coronavirus Vaccine Stock: BioNTech vs. Moderna
95 Better Coronavirus Stock: Biogen or BioNTech?
96 Why BioNTech Stock Vaulted Higher Today
97 BioNTech SE (BNTX) Q2 2020 Earnings Call Transcript
98 Why BioNTech Shares Are Falling Today
99 BioNTech, China's Fosun to potentially supply 10 million doses of COVID-19 vaccine
100 BioNTech SE (BNTX) Is Worth A Look Now, Despite 56.9% Loss From High